The Ministry of Health, Welfare and Sport in the Netherlands Starts With the Sale of the Production Activities of the Netherlands Vaccine Institute

The Ministry of Health, Welfare and Sport (Ministerie van Volkgezondheid, Welzijn en Sport) has Announced That it Commences With the Sale of the Production Activities of the 'Nederlands Vaccin Instituut' (NVI). The Sales Process Starts on February 15, 2011.

THE HAGUE, The Netherlands, February 15, 2011 - In January 2010 the Minister of Health, Welfare and Sport informed the
House of Representatives that the NVI was going to change course. NVI's
public tasks, concerning procurement, warehousing and distribution of
vaccines and the public vaccine research and development tasks, are
integrated into the Dutch National Institute for Public Health and the
Environment (RIVM) as per 1 January 2011. The production of vaccines under
public ownership will be ended. The production and the production facilities
are put up for sale to the private sector.

In the past NVI's production of vaccines played an important role in the
availability of vaccines and vaccines related technology worldwide. NVI
transferred its knowledge on vaccines mainly via the transfer of technology
and stem cells to various public and private institutions.

Within its modern and compliant production facilities, the production
entity in Bilthoven produces biopharmaceutical products such as viral and
bacterial vaccines. Over the years, various types of vaccines have been
produced in a validated and certified production environment.

The present manufacturing activities consist of the production of
inactivated polio vaccine (IPV) as bulk- or final product, BCG vaccines used
in after-surgery treatment of bladder cancer, the combined
diphtheria-tetanus-polio (DTP) vaccine and the tetanus toxoid (Ttox) vaccine
used in the vaccination of children and adults. Contract manufacturing for
third parties is within the scope of activities up for sale. The production
environment, located in the Antonie van Leeuwenhoek Science Park in
Bilthoven, meets the high standards of Good Manufacturing Practices.

The sale of NVI's production activities starts officially on February 15,
2011. American Appraisal has been appointed to act as advisor to the Ministry
of Health Welfare and Sport during the sale of the production activities of
NVI. All parties interested in the abovementioned sales process should state
their interest via American Appraisal, before March 4, 2011.

Contact details: American Appraisal, Drs. Joachim Schulz, Managing Director, Head of Transaction Services Central Europe, Tel: +31-10-2092610, Fax: +31-10-4365305, jschulz at american-appraisal.com;Correspondence address: American Appraisal, Parklaan 44, 3016 BC Rotterdam, The Netherlands